Literature DB >> 9840248

Sweet's syndrome associated with systemic inflammatory response syndrome.

P C Matthews1, S M Willatts.   

Abstract

Septic shock is characterised by infection causing a systemic inflammatory response, end-organ failure and acute circulatory collapse. Treatment consists of antimicrobial therapy and the supportive management of multi-organ failure. We report a case of what we believed to be septic shock due to pyelonephritis in a patient whose condition continued to deteriorate despite conventional treatment until the diagnosis of Sweet's syndrome was made. Once she was started on high dose steroids, her condition improved and she made a full recovery. We believe this to be the first case of a severe systemic inflammatory response syndrome associated with Sweet's syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840248     DOI: 10.1007/s001340050724

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  4 in total

1.  Mimicker of necrotising fasciitis with systemic inflammatory response syndrome: recurrent necrotising Sweet's syndrome associated with chronic myelogenous leukaemia.

Authors:  Kensuke Nakanishi; Mitsuyo Kinjo
Journal:  BMJ Case Rep       Date:  2016-03-31

2.  An Unusual Presentation of Pyoderma Gangrenosum Leading to Systemic Inflammatory Response Syndrome.

Authors:  Ali Didan; Alan Donnelly; Hock Chua
Journal:  Case Rep Dermatol       Date:  2017-09-11

3.  Sterile Neutrophilic Dermatosis (Sweet's Syndrome) Associated With Systemic Inflammatory Response Syndrome in a Maltese Dog: A Case Report.

Authors:  ARom Cho; Hyeona Bae; Sunwoo Shin; Youngju Kim; Yeseul Jeon; Jae-Eun Hyun; Kyu-Woan Cho; Dong-In Jung; Dae Young Kim; DoHyeon Yu
Journal:  Front Vet Sci       Date:  2022-03-21

Review 4.  Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.

Authors:  Philip R Cohen
Journal:  Orphanet J Rare Dis       Date:  2007-07-26       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.